Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.1200 -0.0124 (-9.37%)
Official Closing Price Updated: 8:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Oragenics, Inc. Receives NYSE American Notice
From Oragenics, Inc.
Via Business Wire
Oragenics, Inc. Announces New Chair
From Oragenics, Inc.
Via Business Wire
Oragenics to Participate in the 2022 BioFlorida Annual Conference
From Oragenics, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 115 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 120 companies set new 52-week lows. 
Via Benzinga
Oragenics Issues Letter to Shareholders
From Oragenics, Inc.
Via Business Wire
Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities. 
Via Benzinga
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
From Oragenics, Inc.
Via Business Wire
Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports
From Oragenics, Inc
Via Business Wire
Oragenics Issues Letter to Shareholders
From Oragenics, Inc.
Via Business Wire
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Oragenics's Earnings: A Preview
Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Oragenics will... 
Via Benzinga
Oragenics to Participate at the World Vaccine Congress Washington 2022
From Oragenics, Inc.
Via Business Wire
Earnings Scheduled For April 27, 2022
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter. 
Via Benzinga
Oragenics Extends Collaboration to Develop Vaccines against Future Variants of Coronaviruses
From Oragenics, Inc.
Via Business Wire
68 Biggest Movers From Yesterday
Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares... 
Via Benzinga
Executives Buy Around $5.5M Of 3 Penny Stocks
US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
4 Penny Stocks Insiders Are Buying
US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
From Oragenics, Inc.
Via Business Wire
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
From Oragenics, Inc.
Via Business Wire
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate
Oragenics Inc (NYSE: OGEN) has entered into an agreement with KBI Biopharma Inc for the process transfer, process optimization, and cGMP manufacturing of... 
Via Benzinga
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
5 Stocks Insiders Are Buying Right Now
Several stocks that insiders are buying are worth watching as we enter the new year. This week, that list includes F, CRCT, CHWY and OGEN. 
Via InvestorPlace
45 Biggest Movers From Yesterday
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
Nvidia Omniverse: 14 Things for NVDA Stock Investors to Know About the Metaverse Project
Nvidia (NVDA) is bringing its metaverse project, titled Omniverse, out of beta and letting creators take advantage of the service. 
Via InvestorPlace
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the... 
Via Benzinga
OGEN Stock Alert: The Insider Buying Giving Oragenics Shares Some Oomph Today
Oragenics (OGEN) stock is rising higher on Tuesday following news of massive insider buying at the development-stage company. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.